Here's what Big Pharma could buy in 2025, from obesity drugs to precision cancer treatments, according to a top M&A banker
Jefferies investment banker Chris Roop discussed the Big Pharma M&A outlook with Business Insider. Check out the types of ...
Hosted on MSN2mon
Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed
according to the company, is not an issue of demand or supply. During an earnings call Wednesday, Eli Lilly instead blamed it on drug wholesalers cutting inventory of Zepbound and Mounjaro.
2025 drug price rise: Pharma companies plan to make more than 250 medicines more expensive
Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, ...
Forbes3mon
Drug Companies Are Embracing Direct-To-Consumer Sales. That’s A Win For Patients
Fortunately, that's starting to change. In recent months, drug companies Pfizer and Eli Lilly have begun rolling out direct-to-consumer programs that let patients purchase basic prescriptions ...
CNN10mon
China Jo-Jo Drugstores Incorporated
The Drug Wholesale segment includes supplying its ... The Herb Farming cultivates selected herbs for sales to other drug vendors. The company was founded by Li Qi in September 2003 and is ...